HKEX Stock Code: 01093English|繁體|简体

Highlight - 2020 Interim Results

Revenue
RMB12,590mn, +12.6%
Profit attributable to shareholders
RMB2,314mn, +23.2%
Basic earnings per share
RMB30.97 cents, +23.3%

Key Products

Innovative drugs
Common generic drugs
Bulk drugs
© Copyright 2020 CSPC Pharmaceutical Group Limited. All Rights Reserved.